Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV
- PMID: 20032550
- DOI: 10.3851/IMP1470
Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV
Abstract
The effectiveness of current antiretroviral therapies has led to more patients receiving long-term therapy, and increasing numbers of older patients. The complex interactions between HIV infection, ageing, comorbid conditions and drug-related toxicities, and their combined effects on patient health and quality of life, were the subject of the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV. Key topics included the metabolic effects of antiretroviral agents, cardiovascular disease, bone metabolism and age-related changes in disease and response to drug therapy. Data presented at the meeting reflect the growing recognition of common pathways that contribute to progression of mutiple types of disease and adverse drug reactions.
Similar articles
-
Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.Nat Clin Pract Endocrinol Metab. 2007 Sep;3(9):651-61. doi: 10.1038/ncpendmet0587. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17710086 Review.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Complications of HIV infection in an ageing population: challenges in managing older patients on long-term combination antiretroviral therapy.J Antimicrob Chemother. 2011 Jun;66(6):1210-4. doi: 10.1093/jac/dkr058. Epub 2011 Mar 18. J Antimicrob Chemother. 2011. PMID: 21421583 Review.
-
Antiretroviral therapy: are we aware of adverse effects?J Assoc Physicians India. 2002 Sep;50:1163-71. J Assoc Physicians India. 2002. PMID: 12516702 Review.
-
Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?J HIV Ther. 2003 May;8(2):27-8. J HIV Ther. 2003. PMID: 15587479 No abstract available.
Cited by
-
Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients.J Viral Hepat. 2011 Apr;18(4):e52-60. doi: 10.1111/j.1365-2893.2010.01358.x. J Viral Hepat. 2011. PMID: 20738775 Free PMC article.
-
Proximity of Cytomegalovirus-Specific CD8+ T Cells to Replicative Senescence in Human Immunodeficiency Virus-Infected Individuals.Front Immunol. 2018 Feb 15;9:201. doi: 10.3389/fimmu.2018.00201. eCollection 2018. Front Immunol. 2018. PMID: 29527205 Free PMC article.
-
Pharmacodynamics of PEG-IFN-[alpha]-2a and HCV response as a function of IL28B polymorphism in HIV/HCV-coinfected patients.J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):95-9. doi: 10.1097/QAI.0b013e3182020596. J Acquir Immune Defic Syndr. 2011. PMID: 21157362 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical